ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based,
nutraceutical company devoted to improving the way people age with
its flagship ingredient NIAGEN® and consumer product TRU NIAGEN®,
announced today the expansion of its partnership with A.S. Watson
Group until September 2021, as well as plans to launch TRU NIAGEN
in Watsons Turkey in late 2018.
“We are very fortunate to be working with Watsons and are quite
happy with the success of TRU NIAGEN in Hong Kong. We look
forward to similar successes in other territories,” says Robert
Fried, CEO of ChromaDex.
As part of the expanded agreement, Watsons is committed to
growing the TRU NIAGEN market in Hong Kong and Macau through
mid-September 2021.
"We are very pleased with TRU NIAGEN sales in Hong Kong and
customer feedback has been very positive on its effect. We plan to
expand its distribution across the globe in our other markets in
Asia and Europe," says Malina Ngai, Group Chief Operating Officer
of A. S. Watson Group.
Today, TRU NIAGEN is currently available in over 340 Watsons
stores between Hong Kong, Macau, and Singapore.
Watsons is one of the leading beauty and self-care chain stores
in Turkey with more than 340 stores in over 75 cities.
For additional information on the science supporting TRU NIAGEN
visit www.truniagen.com.
About TRU NIAGEN®:TRU NIAGEN® is a branded
dietary supplement brought to market by key nicotinamide riboside
innovator and patent holder, ChromaDex. NIAGEN® nicotinamide
riboside (NR), also supplied by ChromaDex, is the sole active
ingredient in TRU NIAGEN®. Multiple clinical trials demonstrate
NIAGEN® is proven to boost NAD (nicotinamide adenine dinucleotide)
levels, which decline with age. Only NIAGEN® has twice been
successfully reviewed under FDA's new dietary ingredient (“NDI”)
notification program, and has also been successfully notified to
the FDA as generally recognized as safe (“GRAS”).
About ChromaDex:
ChromaDex Corp. is an integrated, global
nutraceutical company devoted to improving the way people age.
ChromaDex scientists partner with leading universities and research
institutions worldwide to uncover the full potential of NAD and
identify and develop novel, science-based ingredients. Its flagship
ingredient, NIAGEN® nicotinamide riboside, sold directly to
consumers as TRU NIAGEN®, is backed with clinical and scientific
research, as well as extensive IP protection. TRU NIAGEN® is
helping the world AGE BETTER®. ChromaDex maintains a website at
www.chromadex.com to which ChromaDex regularly posts copies of its
press releases as well as additional and financial information
about the Company.
About Watsons:Watsons is Asia’s
leading health and beauty retailer, currently operating over 6,800
stores – more than 1,500 of which are pharmacies, in 11 Asian and
Eastern European markets, including China (Mainland China, Hong
Kong, Macau) and Taiwan, Singapore, Thailand, Malaysia, The
Philippines, Indonesia, Turkey, Ukraine and Russia. Watsons
operates over 230 stores in Hong Kong and Macau, of which over 50
have in-store pharmacies, making Watsons the No. 1 Pharmacy Network
in Hong Kong. Watsons has a professional team of pharmacists,
dieticians, Chinese medicine practitioners, health & fitness
advisors, beauty consultants, an experienced mother & baby
advisor and a nurse.
Watsons continually sets the highest standards
in the health, wellness and beauty market, providing personalized
advice and counselling in health, beauty and personal care on top
of its market-leading product range, making customers LOOK GOOD,
FEEL GREAT every day. Since 2009, Watsons has been the No. 1
Pharmacy/ Drugstore brand in Asia*. In Europe, Watsons is also the
leading Health & Beauty retailer in Ukraine.
*Campaign Asia-Pacific/ Nielsen’s “Asia's Top
1,000 Brands” Online Study 2018 of over 8,000 respondents across 14
markets in Asia Pacific region
About A.S. Watson
Group:Established in Hong Kong in 1841, A.S. Watson Group
is the largest international health and beauty retailer in Asia and
Europe with over 14,400 stores in 24 markets. Each year, over four
billion customers and members shop with A.S. Watson’s 12 retail
brands, both in stores and online.
In Hong Kong, A.S. Watson operates more than 600
stores under four retail brands – Watsons, PARKnSHOP, FORTRESS, and
Watson’s Wine. In addition, A.S. Watson manufactures and
distributes high quality drinking water brand Watsons Water, as
well as the famous juice drinks Mr. Juicy and Sunkist.
For the fiscal year 2017, A.S. Watson Group
recorded revenue of HKD156.2 billion. A.S. Watson has over 130,000
employees worldwide, including 12,900 in Hong Kong.
A.S. Watson Group is also a member of the
world-renowned multinational conglomerate CK Hutchison Holdings
Limited, which has five core businesses ‐ ports and related
services, retail, infrastructure, energy and telecommunications in
over 50 countries.
Please visit www.aswatson.com for more in-depth
information about A.S. Watson Group and its brands. You may also
stay in touch with A.S. Watson via its digital presence (eCommerce,
social media, mobile app & more); more details are at
http://www.aswatson.com/our-customers/digitalasw/.
Forward-Looking Statements:
This release contains forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities and Exchange Act of
1934, as amended. Statements that are not a description of
historical facts constitute forward-looking statements and may
often, but not always, be identified by the use of such words as
"expects", "anticipates", "intends", "estimates", "plans",
"potential", "possible", "probable", "believes", "seeks", "may",
"will", "should", "could" or the negative of such terms or other
similar expressions. More detailed information about ChromaDex and
the risk factors that may affect the realization of forward-looking
statements is set forth in ChromaDex's Annual Report on Form 10-K
for the fiscal year ended December 30, 2017, ChromaDex's Quarterly
Reports on Form 10-Q and other filings submitted by ChromaDex to
the SEC, copies of which may be obtained from the SEC's website at
www.sec.gov. Readers are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date
hereof, and actual results may differ materially from those
suggested by these forward-looking statements. All forward-looking
statements are qualified in their entirety by this cautionary
statement and ChromaDex undertakes no obligation to revise or
update this release to reflect events or circumstances after the
date hereof. ChromaDex provided research materials and a portion of
the grant funding as a collaborator for the study.
ChromaDex Media Contact:Alex Worsham, Director
of Strategic Partnerships949-648-3775alexw@chromadex.com
ChromaDex Investor Relations Contact:Andrew
Johnson, Director of Investor
Relations949-419-0288andrewj@chromadex.com
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Aug 2024 to Sep 2024
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Sep 2023 to Sep 2024